Globus Deferred Long Term Liab from 2010 to 2024
| GMED Stock | USD 84.72 0.19 0.22% |
Deferred Long Term Liabilities | First Reported 2012-06-30 | Previous Quarter 1.4 M | Current Value 5.3 M | Quarterly Volatility 3.2 M |
Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 152 M, Interest Expense of 21.1 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 1.43. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
Globus | Deferred Long Term Liab |
Latest Globus Medical's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Globus Medical over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Globus Medical's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Globus Medical's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Globus Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 5,187,010 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 65.38 | |
| Mean Deviation | 2,920,922 | |
| Median | 6,202,000 | |
| Standard Deviation | 3,391,035 | |
| Sample Variance | 11.5T | |
| Range | 10.7M | |
| R-Value | (0.41) | |
| Mean Square Error | 10.3T | |
| R-Squared | 0.17 | |
| Significance | 0.13 | |
| Slope | (309,782) | |
| Total Sum of Squares | 161T |
Globus Deferred Long Term Liab History
About Globus Medical Financial Statements
Globus Medical stakeholders use historical fundamental indicators, such as Globus Medical's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Globus Medical's assets and liabilities are reflected in the revenues and expenses on Globus Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 1.6 M | 1.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:Check out the analysis of Globus Medical Correlation against competitors. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.